Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
3-1 Month Momentum % is the total return of the stock from 3-month ago to 1-month ago. As of today (2026-09-09), Kuangli Bio-Tech Holdings Co's 3-1 Month Momentum % is 7.67%.
The industry rank for Kuangli Bio-Tech Holdings Co's 3-1 Month Momentum % or its related term are showing as below:
TPE:6431's 3-1 Month Momentum % is ranked better than 64.22% of 2040
companies
in the Consumer Packaged Goods industry
Industry Median: 1.42
vs TPE:6431: 7.67
Kuangli Bio-Tech Holdings Co (TPE:6431) 3-1 Month Momentum % Explanation
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 3-1 Month Momentum % measures the total return to a stock over the past three months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
Kuangli Bio-Tech Holdings Co 3-1 Month Momentum % Related Terms
TPE:6431 vs PG, CL, EL: 3-1 Month Momentum % Comparison
For the Household & Personal Products subindustry, Kuangli Bio-Tech Holdings Co's 3-1 Month Momentum %, along with its competitors' market caps and 3-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kuangli Bio-Tech Holdings Co 3-1 Month Momentum % vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Kuangli Bio-Tech Holdings Co's 3-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where Kuangli Bio-Tech Holdings Co's 3-1 Month Momentum % falls into.
Kuangli Bio-Tech Holdings Co (TPE:6431) 3-1 Month Momentum % Calculation
3-1 Month Momentum % is calculated as following:
3-1 Month Momentum %
=
( Price 1-month ago
/
Price 3-month ago
- 1 )
*
100 %
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kuangli Bio-Tech Holdings Co (TPE:6431) has a 3-1 Month Momentum % of 7.67% as of Sep. 09, 2026. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Kuangli Bio-Tech Holdings Co and its competitors. According to the industry distribution chart, Kuangli Bio-Tech Holdings Co ranks #730 out of 2040 companies in the Consumer Packaged Goods industry, placing it in the top 35.8%.
Is Kuangli Bio-Tech Holdings Co's 3-1 Month Momentum % too high?
Kuangli Bio-Tech Holdings Co's current 3-1 Month Momentum % is 7.67%. The Consumer Packaged Goods industry median 3-1 Month Momentum % is 1.42. Kuangli Bio-Tech Holdings Co's value of 7.67% is 440.1% above this industry median. Based on the distribution chart, Kuangli Bio-Tech Holdings Co ranks #730 out of 2040 companies in the Consumer Packaged Goods industry, which is above the industry midpoint. Overall, Kuangli Bio-Tech Holdings Co has a GF Score™ of 67/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Kuangli Bio-Tech Holdings Co's 3-1 Month Momentum % compare to PG and CL?
According to the Consumer Packaged Goods industry distribution chart, Kuangli Bio-Tech Holdings Co ranks #730 out of 2040 companies for 3-1 Month Momentum %. This puts Kuangli Bio-Tech Holdings Co in the upper half of its industry. The industry median 3-1 Month Momentum % is 1.42. Kuangli Bio-Tech Holdings Co's value of 7.67% is 440.1% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-1 Month Momentum % for a Consumer Packaged Goods company?
The median 3-1 Month Momentum % among Consumer Packaged Goods companies is 1.42, based on 2,040 companies in the industry. Companies in the top quartile (top 25%) have a 3-1 Month Momentum % significantly above this median, while those in the bottom quartile fall well below. However, 3-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Kuangli Bio-Tech Holdings Co's current 3-1 Month Momentum % of 7.67% is 440.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-1 Month Momentum % mean?
A high 3-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Kuangli Bio-Tech Holdings Co and its competitors. For the Consumer Packaged Goods industry, the median 3-1 Month Momentum % is 1.42 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Kuangli Bio-Tech Holdings Co's current 3-1 Month Momentum % is 7.67%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kuangli Bio-Tech Holdings Co stock overvalued right now?
Based on GuruFocus' analysis, Kuangli Bio-Tech Holdings Co (TPE:6431) is currently considered Significantly Overvalued. The stock's GF Value™ is NT$10.58, compared to a current price of NT$19.20 — trading 81.5% above its estimated fair value. The current 3-1 Month Momentum % is 7.67% and 440.1% above the Consumer Packaged Goods industry median of 1.42. Kuangli Bio-Tech Holdings Co's overall GF Score™ is 67/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-1 Month Momentum % calculated?
3-1 Month Momentum % is calculated from a company's financial statements. For Kuangli Bio-Tech Holdings Co (TPE:6431), the current 3-1 Month Momentum % is 7.67% as of Sep. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Kuangli Bio-Tech Holdings Co (TPE:6431) Overvalued in 2026?
Based on GuruFocus' analysis, Kuangli Bio-Tech Holdings Co stock appears to be overvalued.
The current stock price of NT$19.20 is trading 81.5% above its estimated GF Value™ of NT$10.58.
GuruFocus considers Kuangli Bio-Tech Holdings Co to be Significantly Overvalued.
Key valuation signals for TPE:6431:
3-1 Month Momentum %: 7.67%
GF Value™: NT$10.58 vs. price of NT$19.20 (81.5% above fair value)
Industry Position: 440.1% above the Consumer Packaged Goods median (#730 of 2040)
No single metric tells the full story. See the TPE:6431 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Kuangli Bio-Tech Holdings Co Ltd is mainly engaged in the manufacture and trading of various types of panels (LENS), such as mobile phone panels, digital camera windows, PDA panels, and instrument panels. The company is also engaged in the development, manufacturing and trading of cosmetics and skin care products and other related biotechnology products. It derives revenue from Health and Wellness products, and Cosmetics and skin care products, including Lotion, Facial masks, and Other pastes. The primary source of revenue for the company is sales of cosmetic products.
67GF Score
Get the complete analysis for TPE:6431
3-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:6431 has been successfully added to your 
